Research by Marco Loggia, PhD, and his team, found evidence of widespread brain inflammation in veterans of the 1990-1991 Gulf War.
A promising new vaccine under development at Massachusetts General Hospital is raising hope in the urgent search for protection against COVID-19.
A concept known as “prehabilitation” is boosting fitness and overall health for patients preparing for cancer surgery and other demanding treatments.
A consortium of scientists, co-led by Mass General’s Bruce Walker, MD, is working to uncover the biological secrets of the coronavirus.
MGH Research Scholar Katia Georgopolous, PhD, is harnessing a vital mechanism in the human immune system to fight leukemia and other diseases.
Steven Sintros, UniFirst President and CEO, shares why his company chose to support Mass General’s efforts to find a COVID-19 vaccine.
The unrestricted funding of the MGH Research Scholars program empowers scientists to meet the challenges of the COVID-19 pandemic.
Infectious disease experts identify key components – many related to testing – when considering the successful reopening of the country, following COVID-19.
Under the leadership of Keith Flaherty, MD, clinical researchers at Mass General are teaming up to fight the COVID-19 pandemic.
Senior Vice President for Research Harry Orf, PhD, describes how Mass General researchers are responding to the COVID-19 epidemic.